A prospective observational cohort study of patients with castration-resistant prostate cancer (CRPC) in the United States

The purpose of this registry is to describe patterns of care, disease assessment methods, treatment decisions, treatment settings, physician referral patterns and to find out how a patient’s CRPC symptoms have improved while on CRPC therapy.

Contact Candace LeBlanc 508-556-5431 or Marcy Kirkpatrick 508-556-5429 for more information.

For more information about this study: